These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7793156)

  • 1. [Experimental therapy of rheumatoid arthritis with cytokine antagonists].
    Manger B
    Z Rheumatol; 1995; 54(2):105-9. PubMed ID: 7793156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.
    Charles P; Elliott MJ; Davis D; Potter A; Kalden JR; Antoni C; Breedveld FC; Smolen JS; Eberl G; deWoody K; Feldmann M; Maini RN
    J Immunol; 1999 Aug; 163(3):1521-8. PubMed ID: 10415055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
    Christodoulou C; Choy EH
    Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in rheumatoid arthritis: is it all TNF-alpha?
    Miossec P
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):675-8. PubMed ID: 11502074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New approaches to the therapy of rheumatoid arthritis].
    Balabanova RM; Egorova ON
    Ter Arkh; 1996; 68(12):78-82. PubMed ID: 9054051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Innovative approaches in therapy of chronic polyarthritis].
    Keysser G; Burmester GR
    Fortschr Med; 1995 Mar; 113(7):77-80. PubMed ID: 7750887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
    Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance of Th1/Th2 cytokines in rheumatoid arthritis.
    Schulze-Koops H; Kalden JR
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):677-91. PubMed ID: 11812015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine network and its manipulation in rheumatoid arthritis.
    Malaviya AM
    J Assoc Physicians India; 2006 Jun; 54 Suppl():15-8. PubMed ID: 16909710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF alpha as a therapeutic target in rheumatoid arthritis.
    Feldmann M; Brennan FM; Elliott M; Katsikis P; Maini RN
    Circ Shock; 1994 Aug; 43(4):179-84. PubMed ID: 7895323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New approaches to biological immunomodulation therapy of rheumatoid arthritis: neutralization of basic cytokines].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 1998; 70(5):32-7. PubMed ID: 9644739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy.
    Popa C; Netea MG; Barrera P; Radstake TR; van Riel PL; Kullberg BJ; Van der Meer JW
    Cytokine; 2005 Apr; 30(2):72-7. PubMed ID: 15804598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.
    Ounissi-Benkalha H; Pelletier JP; Tardif G; Mineau F; Jolicoeur FC; Ranger P; Martel-Pelletier J
    J Rheumatol; 1996 Jan; 23(1):16-23. PubMed ID: 8838503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The humoral response in rheumatoid arthritis and the effect of B-cell depleting therapy].
    Thurlings RM; Vos K; Gerlag DM; Tak PP
    Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1657-61. PubMed ID: 16922350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F; Murdaca G; Ghio M; Indiveri F
    Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on cytokines in rheumatoid arthritis.
    Brennan F; Beech J
    Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-TNF-alpha therapy as a new option in treatment of rheumatoid arthritis?].
    Leeb BF; Sautner J
    Wien Med Wochenschr; 1999; 149(19-20):554-7. PubMed ID: 10637966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.